APLS - Apellis Pharmaceuticals, Inc.
20.15
0.290 1.439%
Share volume: 2,925,778
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$19.86
0.29
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-01-2024 | 11-05-2024 | 02-28-2025 | 05-07-2025 | 07-31-2025 | 10-30-2025 | 02-24-2026 | |
| Total revenue | 172.325 M | 199.685 M | 196.830 M | 212.527 M | 166.797 M | 178.494 M | 458.578 M | 199.913 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 172.325 M | 199.685 M | 196.830 M | 212.527 M | 166.797 M | 178.494 M | 458.578 M | 199.913 M | |
| 15.88% | -1.43% | 7.97% | -21.52% | 7.01% | 156.92% | -56.41% | |||
| Operating expenses | 214.206 M | 206.028 M | 210.553 M | 197.836 M | 215.765 M | 198.154 M | 210.864 M | 221.336 M | |
| Selling general and admin | 129.505 M | 128.081 M | 121.984 M | 121.483 M | 129.345 M | 131.139 M | 142.678 M | 147.103 M | |
| Research and development | 84.701 M | 77.947 M | 88.569 M | 76.353 M | 86.420 M | 67.015 M | 68.186 M | 74.233 M | |
| Total expenses | 234.415 M | 229.128 M | 244.110 M | 238.693 M | 250.125 M | 211.780 M | 235.395 M | 251.055 M | |
| -2.26% | 6.54% | -2.22% | 4.79% | -15.33% | 11.15% | 6.65% | |||
| Operating income | -62.090 M | -29.443 M | -47.280 M | -26.166 M | -83.328 M | -33.286 M | 223.183 M | -51.142 M | |
| Ebit | -62.589 M | -31.368 M | -47.210 M | -27.931 M | -83.493 M | -33.140 M | 223.220 M | -51.293 M | |
| Pretax income | -66.253 M | -37.543 M | -56.853 M | -36.067 M | -91.884 M | -41.685 M | 216.317 M | -58.638 M | |
| -43.33% | 51.43% | -36.56% | 154.76% | -54.63% | -618.93% | -127.11% | |||
| Income tax | 170.000 K | 114.000 K | 592.000 K | 286.000 K | 341.000 K | 466.000 K | 602.000 K | 313.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -66.423 M | -37.657 M | -57.445 M | -36.353 M | -92.225 M | -42.151 M | 215.715 M | -58.951 M | |
| 43.31% | -52.55% | 36.72% | -153.69% | 54.30% | 611.77% | -127.33% |